Atlas Trials

Ovarian Carcinosarcoma

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Carcinosarcoma

RecordFirmDate
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib (NCT03651206)ARCAGY/ GINECO GROUP2020-07-15
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors (NCT03641287)University of Washington2018-12-05
Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) (NCT03648489)Imperial College London2018-09-21
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108)M.D. Anderson Cancer Center2018-04-27
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707)Mayo Clinic2014-02-24
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (NCT01080521)Gynecologic Oncology Group2010-04-01
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer (NCT00989651)National Cancer Institute (NCI)2009-10-28
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer (NCT01010126)National Cancer Institute (NCI)2009-09-08
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer (NCT00954174)GOG Foundation2009-08-17
Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer (NCT00511992)University of Oklahoma2007-07-01
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma (NCT00390234)National Cancer Institute (NCI)2006-09-01
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer (NCT00352300)Gynecologic Oncology Group2006-06-01
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) (NCT00085358)National Cancer Institute (NCI)2004-05-01

Track Ovarian Carcinosarcoma automatically

Every clearance here is in the API, with alerts when new ones post.